Jan Gerlach

Jan Gerlach serves as COO at enua. enua operates in the pharmaceuticals sector with approximately 45.0 employees. The company is headquartered in Duesseldorf, North Rhine-Westphalia.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • We have verified contacts for 2 executives at enua.
• • 1,069 executive contacts are available in North Rhine-Westphalia.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 Amazon AWS Multilingual Mobile Friendly Quantcast Woo Commerce Google Tag Manager Bootstrap Framework WordPress.org Apache Remote

pharmaceutical manufacturing medical cannabis cannabis therapy prescription cannabis cannabis products gmp certification eu-gmp patient support cannabis strains sativa indica hybrid cannabis online pharmacy telemedicine medical cannabis law cannabis growers canada patient education cannabis prescriptions chronic pain treatment cannabis effects cannabis oil cannabis tinctures cannabis edibles safety & efficacy floral cannabis health benefits of cannabis personalized therapy wellness cannabis delivery apothecary quality management pharmacy partnerships cannabis dosing patient rights evidence-based therapy cannabis research patient reviews pain management cannabis side effects alternative medicine cannabis formulations patient accessibility regulatory compliance patient consultations cannabis distribution social media industry news cannabis cultivation natural remedies telehealth pharmaceuticals medical health care information technology health care health wellness & fitness hospital & health care consumer internet consumers internet information technology & services

A

Albert Managing Partner & CEO at enua

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

Outreach Guidance — pharmaceuticals Sector

Executives like Jan Gerlach in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at enua.

Jan Gerlach's Position in the MessageCEO Database

• •Jan Gerlach is 1 of 2 verified executive contacts we track at enua.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •1,067 verified executive contacts in North Rhine-Westphalia are in the database.
• •10 verified contacts work at pharmaceuticals companies in the 45.0 employee range (same size as enua).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Jan Gerlach directly?

Jan Gerlach's verified email address is available to MessageCEO Pro subscribers. They currently serve as COO at enua. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Jan Gerlach work for?

Jan Gerlach is COO at enua, a company in the pharmaceuticals sector with 45.0 employees. The company is based in Duesseldorf, North Rhine-Westphalia.

Can I pitch or sell to Jan Gerlach?

As COO at enua, Jan Gerlach is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Jan Gerlach directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Jan Gerlach in?

Jan Gerlach works in the pharmaceuticals industry as COO at enua. MessageCEO provides verified contact information for executives across all major industries.

Is Jan Gerlach's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Jan Gerlach's profile is kept up-to-date with the latest available information.

Last updated: July 27, 2026